HCPCS Codes Similar to M1381

HCPCS Codes Similar to “M1381” Code.
Patients with secondary stroke (e.g., a subsequent stroke that may occur with vasospasm in the setting of subarachnoid hemorrhage) within 5 days of the initial procedure

A4300 Implantable access catheter, (e.g., venous, arterial, epidural subarachnoid, or peritoneal, etc.) external access Code added date: 19860101 Code effective date: 20020101 TXT \| PDF \| XML \| JSON	A4301 Implantable access total catheter, port/reservoir (e.g., venous, arterial, epidural, subarachnoid, peritoneal, etc.) Code added date: 19960101 Code effective date: 20030101 TXT \| PDF \| XML \| JSON
G9817 Death did not occur after discharge from the hospital within 30 days post procedure Code added date: 20170101 Code effective date: 20210101 TXT \| PDF \| XML \| JSON	G9815 Death did not occur during the index acute care hospitalization Code added date: 20170101 Code effective date: 20210101 TXT \| PDF \| XML \| JSON
M1238 Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31) Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	G2207 Reason for not administering adjuvant treatment course including both chemotherapy and her2-targeted therapy (e.g. poor performance status (ecog 3-4; karnofsky <=50), cardiac contraindications, insufficient renal function, insufficient hepatic function, other active or secondary cancer diagnoses, other medical contraindications, patients who died during initial treatment course or transferred during or after initial treatment course) Code added date: 20210101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON
M1328 Patients with a diagnosis of acute vitreous hemorrhage Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	G2170 Percutaneous arteriovenous fistula creation (avf), direct, any site, by tissue approximation using thermal resistance energy, and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization) when performed, and includes all imaging and radiologic guidance, supervision and interpretation, when performed Code added date: 20200701 Code effective date: 20230101 TXT \| PDF \| XML \| JSON
G9361 Medical indication for delivery by cesarean birth or induction of labor (<39 weeks of gestation) [documentation of reason(s) for elective delivery (e.g., hemorrhage and placental complications, hypertension, preeclampsia and eclampsia, rupture of membranes (premature or prolonged), maternal conditions complicating pregnancy/delivery, fetal conditions complicating pregnancy/delivery, late pregnancy, prior uterine surgery, or participation in clinical trial)] Code added date: 20140101 Code effective date: 20220101 TXT \| PDF \| XML \| JSON	G9974 Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity Code added date: 20180101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
M1333 Acute vitreous hemorrhage Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	C9754 Creation of arteriovenous fistula, percutaneous; direct, any site, including all imaging and radiologic supervision and interpretation, when performed and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization, when performed) Code added date: 20190101 Code effective date: 20200701 TXT \| PDF \| XML \| JSON
G0045 Clinical follow-up and mrs score assessed at 90 days following endovascular stroke intervention Code added date: 20220101 Code effective date: 20220101 TXT \| PDF \| XML \| JSON	G0046 Clinical follow-up and mrs score not assessed at 90 days following endovascular stroke intervention Code added date: 20220101 Code effective date: 20220101 TXT \| PDF \| XML \| JSON